StockData
Oncolytics Biotech Inc logo

Oncolytics Biotech Inc (ONCY) stock

ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.38+0.04 (+12.53%)

Close on Nov 17, 2026Market cap $48.77MP/E –Yield –

Oncolytics Biotech price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Oncolytics Biotech's price to sales ratio was 79.2× on Feb 28, 2020, against 6.0× a year earlier. Over the last 2 years it ranged from 5.6× to 180.4×, with a median of 22.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2020Feb 28, 202079.2×−101.2
2019Dec 31, 2019180.4×+174.9
2018Dec 31, 20185.6×–

More Oncolytics Biotech figures

See a number that looks wrong?